Node-positive prostate cancer without distant metastases (T any, N+, M0) currently is encountered rarely, primarily because of the shift to diagnosis at earlier stages, a result of widespread PSA testing.
Edward M. Messing, MD, FACS
Advertisement
Articles by Edward M. Messing, MD, FACS
Advertisement
Latest Updated Articles
- N+, M0 Prostate Cancer: Local Therapy for Systemic Disease
Published: July 15th 2013 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
KRd Appears to Exhibit Greater Outcomes in Standard-Risk Multiple Myeloma
2
ADCE-D01 Earns FDA Fast Track Designation in Soft Tissue Sarcoma
3
Serplulimab Plus Chemo Meets EFS End Point in Early-Stage Gastric Cancer
4
212Pb-Dotamtate Prolongs Responses in Advanced GEP-NETs
5
